Men (N = 58239) | Women (N = 61028) | P-value | Overall (N = 119267) | |
---|---|---|---|---|
Age | ||||
Mean (SD) | 67.0 (12.5) | 69.9 (12.7) | < 0.001 | 68.4 (12.7) |
Median [Min, Max] | 68.0 [30.0, 103] | 71.0 [30.0, 109] | 70.0 [30.0, 109] | |
Diabetes | 16,843 (28.9%) | 12,453 (20.4%) | < 0.001 | 29,296 (24.6%) |
Stroke | 2188 (3.8%) | 1752 (2.9%) | < 0.001 | 3940 (3.3%) |
Coronary heart disease (CHD) | 8702 (14.9%) | 4911 (8.1%) | < 0.001 | 13,613 (11.4%) |
Atrial fibrillation (AF) | 8077 (13.9%) | 6238 (10.2%) | < 0.001 | 14,315 (12.0%) |
Gout | 3863 (6.6%) | 1534 (2.5%) | < 0.001 | 5397 (4.5%) |
Congestive heart failure | 4695 (8.1%) | 4049 (6.6%) | < 0.001 | 8744 (7.3%) |
Dementia | 153 (0.3%) | 143 (0.2%) | 0.35 | 296 (0.3%) |
Obesity | 5064 (8.7%) | 5792 (9.5%) | < 0.001 | 10,856 (9.1%) |
Antihypertensive therapy | 51,146 (96.9%) | 53,476 (96.4%) | < 0.001 | 104,622 (96.6%) |
One antihypertensive drug | 1652 (3.1%) | 2013 (3.63%) | < 0.001 | 3665 (3.4%) |
Two antihypertensive drugs | 17,781 (33.7%) | 21,403 (38.6%) | < 0.001 | 39,184 (36.2%) |
Three or more antihypertensive drugs | 33,365 (63.2%) | 32,073 (57.8%) | < 0.001 | 65,438 (60.4%) |
Thiazides | 11,510 (21.8%) | 11,852 (21.4%) | 0.079 | 23,362 (21.6%) |
Calcium antagonists | 24,982 (47.3%) | 22,937 (41.3%) | < 0.001 | 47,919 (44.3%) |
Angiotensin receptor blockers | 21,998 (41.7%) | 24,858 (44.8%) | < 0.001 | 46,856 (43.3%) |
ACE inhibitors | 21,622 (41.0%) | 17,002 (30.6%) | < 0.001 | 38,624 (35.7%) |
Beta blockers | 21,321 (40.4%) | 22,690 (40.9%) | 0.09 | 44,011 (40.6%) |
Aldosterone antagonists | 2461 (4.7%) | 2235 (4.0%) | < 0.001 | 4696 (4.3%) |
Other potassium saving agents | 26 (0.0%) | 38 (0.1%) | 0.24 | 64 (0.1%) |
Aspirin in patients with CHD | 6270 (72.1%) | 3181 (64.8%) | < 0.001 | 9451 (69.4%) |
Statin in patients with CHD/AF/diabetes/stroke | 17,062 (62.8%) | 11,189 (54.4%) | < 0.001 | 28,251 (59.1%) |
Statin in patients without CHD/AF/diabetes/stroke | 7978 (25.7%) | 9683 (23.9%) | < 0.001 | 17,661 (24.7%) |
Anticoagulants or aspirin in patients with stroke | 1858 (84.9%) | 1468 (83.8%) | 0.36 | 3326 (84.4%) |
Tobacco counseling | 1810 (3.2%) | 2180 (3.7%) | < 0.001 | 3990 (3.5%) |
Alcohol counseling | 1725 (3.1%) | 707 (1.2%) | < 0.001 | 2432 (2.1%) |
Physical activity counseling | 16,313 (29.1%) | 15,678 (26.5%) | < 0.001 | 31,991 (27.7%) |
Unhealthy diet counseling | 13,284 (23.7%) | 11,261 (19.0%) | < 0.001 | 24,545 (21.3%) |
Counseling lifestyle | 16,839 (30.0%) | 15,437 (26.1%) | < 0.001 | 32,276 (28.0%) |